This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Topiramate Produced Weight Loss Following Olanzapine-Induced Weight Gain in Schizophrenia

Emmanuelle Levy, Howard C. Margolese, and Guy Chouinard

Published: November 1, 2002

Article Abstract

Letter to the Editor

Sir: Anticonvulsants are increasingly used as an augmentation strategy in schizophrenia. Topiramate, with the unique side effect of reducing appetite and weight, was found effective as a mild-to-moderate mood stabilizer. Topiramate was found to produce weight loss after clozapine induced weight gain in a schizophrenic patient. We report here the effect of topiramate in a patient with schizophrenia and olanzapine-induced weight gain.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 63

Quick Links: Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...